推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 中國心連心化肥9月中旬以來股價(jià)展開了升浪，填滿了2月以來下跌造的“坑”。今日盤中高見2.79港元，創(chuàng)52周新高，截至14時(shí)15分，漲5.43%，報(bào)價(jià)2.72港元，成交額為1485萬港元。
據(jù)智通財(cái)經(jīng)了解，國內(nèi)外尿素價(jià)格持續(xù)上漲提振了中國心連心化肥業(yè)績預(yù)期，造成股價(jià)上漲。
尿素價(jià)格上漲利好原因有三：一是環(huán)保壓力持續(xù)，尿素企業(yè)的開工率維持在55%左右，開工不足，雖然農(nóng)業(yè)需求不旺，但復(fù)合肥企業(yè)和膠合板廠的需求尚存;二是原料煤炭價(jià)格一路上漲，產(chǎn)地煤炭供應(yīng)偏緊，汽運(yùn)費(fèi)上漲，鐵路車皮計(jì)劃緊張，5500打卡動(dòng)力煤港口平倉價(jià)690-695元/噸，貿(mào)易商捂盤惜售，坐等煤價(jià)突破700元大關(guān);三是國際行情看好，大小顆粒全面看漲，印度招標(biāo)數(shù)量和價(jià)格可觀，給國內(nèi)尿素帶來利好。
此外，市場(chǎng)人士認(rèn)為，中國心連心化肥不再是單一的的化肥企業(yè)，轉(zhuǎn)型成為煤化工企業(yè)，戰(zhàn)略成功。新疆煤礦預(yù)計(jì)2017年底建設(shè)完畢，2018年一季度開始產(chǎn)煤，預(yù)計(jì)全年可以供應(yīng)60萬噸以上，將對(duì)2018年公司業(yè)績產(chǎn)生重大影響。同時(shí)，其業(yè)務(wù)不再依靠尿素、復(fù)合肥等產(chǎn)品，產(chǎn)業(yè)鏈向下延伸，拓展至盈利能力更強(qiáng)的三聚氰胺、液氨和甲醇產(chǎn)品。業(yè)績上已經(jīng)迎來了拐點(diǎn)。
